Sort
40,608 grants matching “prostate cancer”
NEUROPILIN-2 INHIBITOR AS A POTENT THERAPY FOR PROSTATE CANCER BONE METASTASIS.
$699,760Board Of Regents Of The University Of Nebraska · · FY2021 · Defense Health Agency
DISCOVERY OF NOVEL GENE ELEMENTS ASSOCIATED WITH PROSTATE CANCER PROGRESSION
$699,735Regents Of The University Of Michigan · · FY2011 · Department of the Army
Patient-Clinician Information Exchange: Determinants and Effects on Health Behavi
$699,674Robert C. Hornik · University Of Pennsylvania · P20 · FY2009 · CA
Computerized histologic image predictor of cancer outcome
$699,670Anant Madabhushi · Case Western Reserve University · R01 · FY2016 · CA
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$699,632Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
AWARD NUMBER/PROJECT TITLE: W81XWH2110076/B7-H3 (CD276) AS A THERAPEUTIC TARGET IN LETHAL PROSTATE CANCERS.
$699,534Institute Of Cancer Research: Royal Cancer Hospital (The) · · FY2021 · Department of the Army
Stanford Molecular and Cellular Characterization Laboratory
$699,416James D Brooks · Stanford University · U01 · FY2017 · CA
Core 2
$699,371Andrea Califano · Columbia University Health Sciences · U54 · FY2011 · CA
Theranostic DLL3/PSMA-bi-specific CAR-T cells for prostate cancer therapy
$699,311Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Maryland Prostate Cancer Case-Control Study
$699,227Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Harvard/Michigan/Cornell Prostate Cancer Biomarker Clinical Validation Center
$699,142Martin G Sanda · Beth Israel Deaconess Medical Center · U01 · FY2011 · CA
Population Modeling of Bladder Cancer Detection and Control
$699,128Thomas Trikalinos · Brown University · U01 · FY2025 · CA
A selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
$699,109Shalendar Bhasin · Brigham And Women'S Hospital · R01 · FY2019 · NR
Stroger Hospital of Cook County, Department of Surgery,*
$699,027Thomas Lad · Hektoen Institute For Medical Research · U10 · FY2009 · CA
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion
$698,955Michael M. Ittmann · Baylor College Of Medicine · U01 · FY2011 · CA
IMPROVED MRI/MRSI FOR BIOPSY GUIDANCE OF PROSTATE CANCER
$698,839University Of California San Francisco · R33 · FY2002 · CA
Role of Neurotrophins in the Development of the Mammalian Nervous System
$698,761Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
TARGETING A NOVEL INTRACELLULAR ISOFORM OF OSTEOPONTIN IN INNATE IMMUNITY TO SUPPRESS PROSTATE CANCER
$698,750Duke University · · FY2011 · Department of Defense
MOUSE CANCER MODELS BY REGULATED INACTIVATION OF TUMOR S
$698,719University Of California Irvine · U01 · FY2003 · CA
ESCAPE - Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate Cancer
$698,716Timothy McClure · Weill Medical Coll Of Cornell Univ · R37 · FY2025 · CA
ESCAPE - Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate Cancer
$698,716Timothy McClure · Weill Medical Coll Of Cornell Univ · R37 · FY2024 · CA
Program for the Elimination of Cancer Disparities (PECAD)
$698,526Graham A Colditz · Washington University · U54 · FY2013 · CA
DECISION ANALYSIS OF THE BENEFITS AND COSTS OF SCREENING FOR PROSTATE CANCER
$698,473Dana-Farber Cancer Institute, Inc. · · FY2009 · Department of the Army
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI
$698,454Daniel B Vigneron · University Of California, San Francisco · R01 · FY2015 · EB
EPIGENETIC CONTROL OF PROSTATE CANCER METASTASIS: ROLE OF RUNX2 PHOSPHORYLATION
$698,342Regents Of The University Of Michigan · · FY2011 · Department of Defense